On this page
WDPCP
WD repeat containing planar cell polarity effector
WDPCP is located on the short (p) arm of chromosome 2, at band 2p15. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 2 in the library →Available at Jeen Health
Clinical tests that include this
Overview
WDPCP (WD repeat containing planar cell polarity effector) encodes a protein essential for establishing planar cell polarity and regulating ciliary function across multiple tissues. The gene is located on chromosome 2p15 and produces a 746-amino-acid protein containing WD repeat domains that facilitate protein-protein interactions.
Biallelic pathogenic variants in WDPCP cause a range of ciliopathy phenotypes characterised by abnormalities in organs dependent on proper cilia structure and function. These conditions affect the kidneys, skeleton, eyes, and central nervous system. WDPCP-related disorders follow autosomal recessive inheritance, meaning affected individuals carry pathogenic variants on both gene copies.
What the gene does
The WDPCP protein functions as a planar cell polarity effector, coordinating the orientation of cells within tissue planes during development. This protein localises to the base of primary cilia and transition zones, where it regulates ciliogenesis and helps maintain ciliary architecture.
Cilia are microscopic, hair-like projections on cell surfaces that serve sensory and signalling functions. The WDPCP protein contributes to both the assembly of these structures and the planar arrangement of ciliated cells in epithelial tissues. Through its WD repeat domains, WDPCP interacts with other planar cell polarity pathway components to establish directional information that guides tissue patterning.
Disruption of WDPCP function impairs cilia formation and stability, leading to defective sensory signalling and developmental abnormalities in tissues such as renal tubules, skeletal elements, and the neural tube. The protein appears particularly important in organs where coordinated ciliary beating or signalling is required for normal development and function.
Video: Genetics 101
Chromosome location
WDPCP is located on the short arm of chromosome 2 at position p15 (cytogenetic band 2p15). This chromosomal region contains genes involved in diverse developmental processes. The precise genomic coordinates and exon-intron structure of WDPCP determine how the gene is transcribed and regulated across different tissues during development.
Protein structure
The WDPCP protein comprises 746 amino acids and contains two WD repeat domains that form the structural basis for its interactions with other cellular proteins. WD 1 (Repeat) spans amino acids 326-374, whilst WD 2 (Repeat) extends from positions 375-414.
WD repeats typically fold into a propeller-shaped structure that serves as a platform for assembling protein complexes. These domains enable WDPCP to coordinate with planar cell polarity pathway components and ciliary proteins, facilitating its role in organising cellular architecture and cilia positioning.
Key variants
Pathogenic variants in WDPCP are predominantly loss-of-function changes, including nonsense mutations, frameshift deletions or insertions, and splice-site alterations that disrupt protein production or stability. Missense variants affecting functionally critical residues within the WD repeat domains have also been reported.
The spectrum of WDPCP variants identified to date reflects the gene's autosomal recessive inheritance pattern, with affected individuals carrying biallelic pathogenic changes.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
Biallelic WDPCP variants cause a spectrum of ciliopathy phenotypes with variable severity and organ involvement. Affected individuals may present with renal anomalies such as cystic kidney disease, skeletal abnormalities including short ribs and limb malformations, retinal dystrophy, and intellectual disability.
Some individuals exhibit features overlapping with Jeune asphyxiating thoracic dystrophy or Bardet-Biedl syndrome, reflecting the shared cellular mechanisms underlying different ciliopathies. The range of clinical presentations suggests that residual WDPCP function, genetic modifiers, and environmental factors may influence phenotypic severity.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
Inheritance pattern
Conditions caused by pathogenic WDPCP variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
WDPCP holds green classification status across multiple NHS Genomic Medicine Service gene panels, reflecting robust clinical evidence for its role in inherited disease. The gene appears on panels including DDG2P, Fetal anomalies (R21), Intellectual disability (R29), Limb disorders, Ophthalmological ciliopathies, Rare multisystem ciliopathy disorders, Renal ciliopathies, Retinal disorders (R32), and Skeletal dysplasia (R104).
This broad panel representation underscores the multisystem nature of WDPCP-related disorders and supports testing in individuals with ciliopathy features affecting renal, skeletal, ocular, or neurological systems.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What inheritance pattern do WDPCP variants follow?
WDPCP-related conditions are inherited in an autosomal recessive pattern. An affected individual has inherited a pathogenic variant from each parent, who are typically unaffected carriers.
Why does WDPCP affect multiple organ systems?
WDPCP encodes a protein essential for cilia function, and cilia play critical roles in the kidneys, skeleton, eyes, and brain during development. Disruption of ciliary processes therefore produces multisystem abnormalities characteristic of ciliopathies.
Can WDPCP variants be detected through genetic testing?
Yes, pathogenic WDPCP variants can be identified through targeted gene panel testing, exome sequencing, or genome sequencing, particularly in individuals presenting with features consistent with ciliopathy disorders.